{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T10:31:48Z","timestamp":1753180308558,"version":"3.38.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.transproceed.2024.10.030","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T04:41:47Z","timestamp":1733460107000},"page":"298-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of CYP 3A4*1B and CYP3A5*3 Gene Polymorphisms in Antirejection of Tacrolimus in Liver Transplant Patients"],"prefix":"10.1016","volume":"57","author":[{"given":"Xia","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rujia","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinjie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2024.10.030_bib0001","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/lt.21104","article-title":"MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure[J]","volume":"13","author":"Yantorno","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0002","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1097\/TP.0000000000002700","article-title":"Improved survival in liver transplant patients receiving Prolonged-release tacrolimus-based immunosuppression in the European Liver Transplant Registry (ELTR): an extension study","volume":"103","author":"Adam","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0003","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bcpt.13539","article-title":"Temporary decrease in tacrolimus clearance in cytochrome P450 3A5 non-expressors early after living donor kidney transplantation: Effect of interleukin 6-induced suppression of the cytochrome P450 3A gene","volume":"128","author":"Enokiya","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0004","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1060028019871891","article-title":"Clinical controversy in transplantation:\u2002tacrolimus\u2002versus cyclosporine in statin drug interactions[J]","volume":"54","author":"Migliozzi","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0005","article-title":"Development of an electrochemical DNA-based biosensor for the detection of the cardiovascular pharmacogenetic -altering SNP CYP2C9*3","volume":"264","author":"Magalh\u00e3es","year":"2023","journal-title":"Talanta"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0006","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2018.12.124","article-title":"Inhibition of cytochrome P450 3A protein degradation and subsequent increase in enzymatic activity through p38 MAPK activation by acetaminophen and salicylate derivatives","volume":"509","author":"Ohtsuki","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0007","article-title":"Tacrolimus\u2002therapeutic efficacy in post-liver transplant patients with\u2002Cytochrome\u2002P450\u20023A5 (CYP3A5) genetic polymorphisms","volume":"47","author":"Bezerra","year":"2020","journal-title":"Rev Col Bras Cir"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0008","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.3748\/wjg.v23.i7.1224","article-title":"Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level","volume":"23","author":"Eshraghian","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0009","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/psp4.12420","article-title":"A minimal physiologically-based pharmacokinetic model for tacrolimus in living-donor liver transplantation: perspectives related to liver regeneration and the cytochrome P450 3A5 (CYP3A5) genotype","volume":"8","author":"Itohara","year":"2019","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115000","article-title":"Effect of CYP3A4*22 and CYP3A4*1B but not CYP3A5*3 polymorphisms on tacrolimus pharmacokinetic model in Tunisian kidney transplant","volume":"396","author":"Hannachi","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0011","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/1060028019897050","article-title":"Impact of donor and recipient CYP3A5*3 Genotype on\u2002tacrolimus\u2002population pharmacokinetics in Chinese adult liver transplant recipients[J]","volume":"54","author":"Shao","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1201083","article-title":"Effects of CYP3A4*22 polymorphism on trough concentration of tacrolimus in kidney transplantation: a systematic review and meta-analysis","volume":"14","author":"Kim","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0013","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/cpt.113","article-title":"Clinical pharmacogenetics implementation consortium (CPIC) guidelines for CYP 3A5 genotype and tacrolimus dosing","volume":"98","author":"Birdwell","year":"2015","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0014","first-page":"2675","article-title":"Polymorphisms of drug -metabolizing enzymes genes in a Han Chinese population [J]","volume":"089","author":"Liu","year":"2009","journal-title":"National Medical Journal of China"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4285\/kjt.2020.34.1.24","article-title":"Effect of cytochrome P450 3A5 polymorphism on the pharmacokinetics of tacrolimus in renal transplant recipients","volume":"34","author":"Htun","year":"2020","journal-title":"Korean J Transplant"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0016","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.3390\/ijms21124347","article-title":"CYP3A5 genotype as a potential pharmacodynamic biomarker for\u2002tacrolimus\u2002therapy in ulcerative colitis in Japanese patients","volume":"21","author":"Yamamoto","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0017","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/ajt.15205","article-title":"Outcomes of immunosuppression minimization and withdrawal early after liver transplantation","volume":"19","author":"Shaked","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0019","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/FPC.0000000000000321","article-title":"Influence of donor liver CYP3A4*20 loss-of-function genotype on tacrolimus pharmacokinetics in transplanted patients","volume":"28","author":"G\u00f3mez-Bravo","year":"2018","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2217\/pgs-2019-0120","article-title":"CYP 3A5*3 and CYP 2C8*3 variants influence exposure and clinical outcomes of\u2002tacrolimus-based therapy","volume":"21","author":"Genvigir","year":"2020","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0021","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.3390\/jcm9092897","article-title":"Effect of CYP 3A5 on the once-daily tacrolimus conversion in stable liver transplant patients","volume":"9","author":"Kim","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.transproceed.2024.10.030_bib25","first-page":"1874","article-title":"Influences of ABCB1 polymorphism on the dose adjusted blood concentration of tacrolimus and renal function in renal transplant recipients with cytochrome P450 3A5 * 3\/* 3 genotype","volume":"033","author":"Ma","year":"2017","journal-title":"Chin J Clin Pharmacol"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0022","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1038\/s41598-019-41820-y","article-title":"Influence of CYP3A4\/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer","volume":"9","author":"Ozeki","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.transproceed.2024.10.030_bib0023","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.3390\/ijms20102413","article-title":"Impact of CYP 3A5, POR, and CYP2C19 polymorphisms on trough concentration to dose ratio of tacrolimus in allogen EIC hematopoietic stem cell transplantation","volume":"20","author":"Suetsugu","year":"2019","journal-title":"Int J Mol Sci"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524005633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134524005633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T17:47:23Z","timestamp":1740505643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134524005633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0041134524005633"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.10.030","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of CYP 3A4*1B and CYP3A5*3 Gene Polymorphisms in Antirejection of Tacrolimus in Liver Transplant Patients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2024.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}